Addiction and the pharmacology of cannabis: implications for medicine and the law.
The topic of drug addiction or misuse of drugs has numerous far-reaching ramifications into areas such as neuroscience, medicine and therapeutics, toxicology, epidemiology, national and international economics and politics, and the law. The general principles of drug addiction are first summarised. A recurring and intrinsic problem is lack of adequate characterisation of the independent variable, namely the drug taken. Secondly, it is not feasible to allocate subjects randomly to treatments. Thirdly, the heterogeneity of different forms of addiction precludes facile generalisations. "A problem drug user is anyone who experiences social, psychological, physical, or legal problems related to intoxication, and/or regular excessive consumption, and/or dependence as a consequence of their use of drugs" (UK Advisory Council on Misuse of Drugs, 1982). Cannabis is a genus of flowering plants whose products are used as recreational drugs. Claims have been made for a range of therapeutic properties. Its two main active principles are delta9 - tetrahydrocannabinol (THC) and cannabidiol (CBD). These compounds have contrasting pharmacological properties. THC is suspected of causing psychotic phenomena, but CBD seems more sedative and may even be antipsychotic. The past use of cannabis, particularly the concentrations of THC and CBD, can be monitored with hair analysis. Recent studies involving the administration of THC and CBD to human subjects are reviewed. Suggestions are made for further research into the pharmacology and toxicology of CBD. Such data may also point to a more rational evidence-based approach to the legal control of cannabis preparations.
Lader
Malcolm
M
Institute of Psychiatry King's College, Denmark Hill, London SE5 8AF. m.lader@iop.kcl.ac.uk
D002188:Cannabis / Q000009:adverse effects / Q000737:chemistry; D004335:Drug and Narcotic Control; D006801:Humans; D002189:Marijuana Abuse / Q000175:diagnosis / Q000503:physiopathology / Q000523:psychology; D008517:Phytotherapy; D028321:Plant Preparations / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000209:etiology
D028321:Plant Preparations